Medabon (mifepristone + misoprostol combi-pack)

$75.46

3 products sold in last 11 hours
Selling fast! Over 8 people have in their cart

Medabon 200 mg Tablet is a prescription medication used for the medical termination of intrauterine pregnancy up to 63 days (9 weeks) of gestation. This combination therapy includes Mifepristone and Misoprostol, which work together to safely end an early pregnancy under the guidance of a qualified healthcare professional.

27 people are viewing this right now
  • Check Mark Estimated Delivery : Up to 4 business days
  • Check Mark Free Shipping & Returns : On all orders over $200
  • Visa Card
  • MasterCard
  • American Express
  • Discover Card
  • PayPal
  • Apple Pay
Guaranteed Safe And Secure Checkout

Medabon 200mg Tablet Overview & Research Applications

Medabon 200mg Tablet is a clinically established medical abortion formulation that combines mifepristone and misoprostol for non-surgical termination of early pregnancy, typically up to 9 weeks of gestation. In reproductive health research and supervised medical practice, clinicians value Medabon for its predictable mechanism of action, standardized dosing, and documented outcomes.

Consequently, Medabon 200mg Tablet frequently appears in obstetric and gynecological studies as an alternative to surgical procedures, particularly when patient privacy, recovery time, and non-invasive management remain priorities. When used under proper medical guidance, it supports evidence-based early pregnancy management.

Active Ingredients in Medabon 200mg Tablet

Medabon 200mg Tablet contains two active pharmaceutical components that work sequentially:

  • Mifepristone (200 mg) – Blocks progesterone, the hormone required to maintain pregnancy. As a result, the uterine lining breaks down and pregnancy progression stops.

  • (200 mcg tablets) – A prostaglandin analogue that induces uterine contractions and cervical softening, allowing expulsion of pregnancy tissue.

Together, these ingredients form a widely researched combination commonly referred to as mifepristone–misoprostol therapy.

Research Use & Intended Applications

Healthcare professionals and researchers reference Medabon 200mg Tablet for several supervised applications. For example, it supports:

  • Medical termination of early pregnancy within approved gestational limits

  • Research on non-surgical abortion protocols

  • Studies evaluating prostaglandin-induced uterine response

  • Clinical comparisons between medical and procedural abortion outcomes

Because of its consistent pharmacological profile, Medabon remains an important subject in reproductive medicine research and treatment guidelines.

Safety & Handling Considerations

Although extensive research supports Medabon 200mg Tablet, safe use requires medical oversight. During the process, individuals may experience bleeding, cramping, nausea, vomiting, diarrhea, fever, or chills. These effects usually indicate the expected physiological response to treatment.

However, users should monitor symptoms carefully. Severe abdominal pain, excessive bleeding, prolonged fever, or signs of infection require immediate medical attention.

Who Should Avoid Using Medabon 200mg Tablet

Medabon 200mg Tablet does not suit every individual. Therefore, healthcare professionals typically advise against use in the following situations:

  • Confirmed or suspected ectopic pregnancy

  • Known hypersensitivity to mifepristone, misoprostol, or prostaglandins

  • Chronic adrenal failure or bleeding disorders

  • Long-term anticoagulant therapy

  • Uncontrolled asthma or serious systemic illness

A qualified healthcare provider must assess eligibility before use.

Dosage Guidelines for Medabon 200mg Tablet

Dosage follows established medical protocols and professional instruction. In most supervised regimens:

  • Day 1: One tablet of mifepristone 200 mg taken orally

  • After 24–48 hours: Four tablets of misoprostol 200 mcg administered as directed (oral, buccal, or vaginal route depending on guidance)

  • Follow-up: Clinical evaluation within 7–14 days to confirm completion

Importantly, users should never alter dosage or timing without medical advice.

Storage & Handling

To maintain effectiveness and safety, follow these storage recommendations:

  • Store at room temperature between 15°C and 25°C

  • Protect from direct sunlight and moisture

  • Keep securely out of reach of children

  • Do not use after the printed expiration date

Quality Assurance & Authenticity

Acute Pharmacy ® ™ sources Medabon 200mg Tablet exclusively through verified pharmaceutical supply chains. As a result, each product includes sealed packaging, accurate labeling, batch traceability, and quality control checks that align with regulated medical distribution standards.

Frequently Asked Questions–Medabon 200mg Tablet

What is a Medabon tablet used for?
Healthcare professionals use Medabon for medical termination of early pregnancy under supervision, using a combination of mifepristone and misoprostol.

How many days does it take for mifabon to work?
Initial effects typically begin within hours after misoprostol administration, while the full process usually completes within 1–3 days.

What is the pill for 1 month pregnancy removed?
Medical professionals commonly prescribe mifepristone followed by misoprostol for early pregnancy management, depending on gestational age and suitability.

Can misoprostol remove 3 months of pregnancy?
Medical guidelines limit misoprostol use to specific gestational periods under supervision. A healthcare provider must evaluate gestational age and safety before use.

Order with Confidence from Acute Pharmacy ® ™

Acute Pharmacy ® ™ provides discreet, quality-assured access to authenticated pharmaceutical products. Each order receives professional handling, verified sourcing, and clear usage information, allowing customers to proceed with confidence, safety, and trust.
Add to cart today for reliable research-grade quality you can trust.

Reviews

There are no reviews yet.

Be the first to review “Medabon (mifepristone + misoprostol combi-pack)”

Your email address will not be published. Required fields are marked *